Hand impairment is one of the most common and debilitating consequences of neurological injury and disease, affecting people living with spinal cord injury (SCI), stroke survivors, and a growing aging population facing conditions like traumatic brain injury and neurodegenerative decline. Despite how widespread the problem is, most rehabilitation tools are narrow in scope, costly to deliver, and produce limited functional outcomes. There is a clear unmet need for accessible, evidence-based solutions that can restore hand function and independence across the full spectrum of neurorehabilitation, from acute SCI to aging-related brain health.
MyHand® by iRegained is a digital therapy platform that uses personalized exercises and interactive games to restore hand function through neuroplasticity, the brain's ability to rewire and relearn. Developed for anyone experiencing hand impairment from neurological injury or disease, including SCI, stroke, and traumatic brain injury, the system is designed to serve a broad and growing population across the neurorehabilitation spectrum.
With support from Praxis Spinal Cord Institute, MyHand® was adapted and piloted for the SCI community, with patients reporting meaningful gains in grip strength and daily independence. Early data suggest cost savings of around $160 per patient per year alongside reduced clinician burden and lower caregiver reliance.
MyHand® is currently available at three locations in Canada and four in the US, with a clear mission to expand access across more clinics and communities.
